UPDATED RESULTS FROM THE RUBY-3 STUDY OF POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS

15 Apr 2024 5:45 p.m. 6:45 p.m.
WCN24-AB-762, Poster Board= MON-304
James Tumlin Poster Presenter